BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20713897)

  • 1. Ca2+/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy.
    Toko H; Takahashi H; Kayama Y; Oka T; Minamino T; Okada S; Morimoto S; Zhan DY; Terasaki F; Anderson ME; Inoue M; Yao A; Nagai R; Kitaura Y; Sasaguri T; Komuro I
    Circulation; 2010 Aug; 122(9):891-9. PubMed ID: 20713897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure.
    Bossuyt J; Helmstadter K; Wu X; Clements-Jewery H; Haworth RS; Avkiran M; Martin JL; Pogwizd SM; Bers DM
    Circ Res; 2008 Mar; 102(6):695-702. PubMed ID: 18218981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
    Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
    Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure.
    Sag CM; Wadsack DP; Khabbazzadeh S; Abesser M; Grefe C; Neumann K; Opiela MK; Backs J; Olson EN; Brown JH; Neef S; Maier SK; Maier LS
    Circ Heart Fail; 2009 Nov; 2(6):664-75. PubMed ID: 19919992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.
    Huby AC; Turdi S; James J; Towbin JA; Purevjav E
    Clin Sci (Lond); 2016 Feb; 130(4):289-99. PubMed ID: 26566650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy.
    Beauverger P; Ozoux ML; Bégis G; Glénat V; Briand V; Philippo MC; Daveu C; Tavares G; Roy S; Corbier A; Briand P; Dorchies O; Bauchet AL; Nicolai E; Duclos O; Tamarelle D; Pruniaux MP; Muslin AJ; Janiak P
    Cardiovasc Res; 2020 Feb; 116(2):329-338. PubMed ID: 31038167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.
    Zhang T; Guo T; Mishra S; Dalton ND; Kranias EG; Peterson KL; Bers DM; Brown JH
    Circ Res; 2010 Feb; 106(2):354-62. PubMed ID: 19959778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis.
    Zhao J; Yin M; Deng H; Jin FQ; Xu S; Lu Y; Mastrangelo MA; Luo H; Jin ZG
    Cell Death Differ; 2016 Apr; 23(4):695-706. PubMed ID: 26517531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced oxidative stress resets the Ca2+ dependence of Ca2+-calmodulin protein kinase II and promotes a death pathway conserved across different species.
    Palomeque J; Rueda OV; Sapia L; Valverde CA; Salas M; Petroff MV; Mattiazzi A
    Circ Res; 2009 Dec; 105(12):1204-12. PubMed ID: 19850941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy.
    Iwata Y; Ohtake H; Suzuki O; Matsuda J; Komamura K; Wakabayashi S
    Cardiovasc Res; 2013 Sep; 99(4):760-8. PubMed ID: 23786999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats.
    Daniels LJ; Wallace RS; Nicholson OM; Wilson GA; McDonald FJ; Jones PP; Baldi JC; Lamberts RR; Erickson JR
    Cardiovasc Diabetol; 2018 Jun; 17(1):89. PubMed ID: 29903013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
    Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
    Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium/Calmodulin Protein Kinase II-Dependent Ryanodine Receptor Phosphorylation Mediates Cardiac Contractile Dysfunction Associated With Sepsis.
    Sepúlveda M; Gonano LA; Viotti M; Morell M; Blanco P; López Alarcón M; Peroba Ramos I; Bastos Carvalho A; Medei E; Vila Petroff M
    Crit Care Med; 2017 Apr; 45(4):e399-e408. PubMed ID: 27648519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy.
    Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME
    Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis.
    Mazelin L; Panthu B; Nicot AS; Belotti E; Tintignac L; Teixeira G; Zhang Q; Risson V; Baas D; Delaune E; Derumeaux G; Taillandier D; Ohlmann T; Ovize M; Gangloff YG; Schaeffer L
    J Mol Cell Cardiol; 2016 Aug; 97():213-25. PubMed ID: 27133769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release.
    Maier LS; Zhang T; Chen L; DeSantiago J; Brown JH; Bers DM
    Circ Res; 2003 May; 92(8):904-11. PubMed ID: 12676813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy.
    Nakano SJ; Walker JS; Walker LA; Li X; Du Y; Miyamoto SD; Sucharov CC; Garcia AM; Mitchell MB; Ambardekar AV; Stauffer BL
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1221-H1230. PubMed ID: 31625780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
    Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.